Safety concerns of sodium-glucose co-transporter-2 inhibitors in type 1 diabetes: A real-world study from the perspective of the Food and Drug Administration Adverse Event Reporting System.
-
アブストラクト ジャーナル名 Diabetes, obesity & metabolism 投稿日 2020/7/8 投稿者 Zhou, Xiang; Zhou, Yangzhong; Li, Xuemei; Xiao, Xinhua 組織名 Department of Endocrinology, Key Laboratory of Endocrinology of National Health;and Family Planning Commission, Peking Union Medical College Hospital, Chinese;Academy of Medical Science and Peking Union Medical College, Beijing, China.;Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy;of Medical Science and Peking Union Medical College, Beijing, China. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/32633000/ -
お問合わせ
検索
メルマガ登録
